CN Patent

CN105683188A — 作为fgfr4抑制剂的稠环二环吡啶基衍生物

Assigned to Novartis AG · Expires 2016-06-15 · 10y expired

What this patent protects

本发明提供式(I)化合物或其可药用盐；制造所述化合物的方法及其治疗用途。本发明进一步提供药理学活性剂的组合以及包含所述化合物的药物组合物。

USPTO Abstract

本发明提供式(I)化合物或其可药用盐；制造所述化合物的方法及其治疗用途。本发明进一步提供药理学活性剂的组合以及包含所述化合物的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number: CN105683188A
Jurisdiction: CN
Classification: —
Expires: 2016-06-15
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.